Bluebird Bio Prevails in Delaware Patent Dispute Over Gene Therapy Treatments

In a recent legal victory for Bluebird Bio, a Delaware federal judge dismissed a lawsuit alleging that the company’s gene therapy treatments for blood disorders infringed patents held by San Rocco Therapeutics LLC. The case was significantly affected by a preceding claim construction ruling, which played a crucial role in the judge’s decision to toss the lawsuit. These gene therapy treatments, which are valued in the multimillion-dollar range, were at the center of the litigation. For more detailed insights into this case, you may refer to the report available here.